PV Reporter (@PVReporter) header
PV Reporter (@PVReporter) profile picture

PV Reporter

@PVReporter

PV Reporter provides tools for MPN research. David Wallace - Founder, Fierce PV patient & advocate. CEO of non-profit https://teapawt.org/t.co/6GLZHJGuac

 Charlotte, NC
PVReporter.com
Joined September 2013
  • Tweets786
  • Following786
  • Followers907
222Media
Photo by PV Reporter (@PVReporter)Photo by PV Reporter (@PVReporter)Photo by PV Reporter (@PVReporter)Photo by PV Reporter (@PVReporter)Photo by PV Reporter (@PVReporter)Photo by PV Reporter (@PVReporter)Photo by PV Reporter (@PVReporter)Photo by PV Reporter (@PVReporter)Photo by PV Reporter (@PVReporter)Photo by PV Reporter (@PVReporter)
#EHA23 #EHA2023 #MPNSM | Outstanding talk by Dr @HarryGillHKUMed | RopegIFN for patients with earlier Myelofibrosis (MF) showing possibility of #DiseaseModification in MPN | @harrisoncn1
Image from Naveen Pemmaraju, MD (@doctorpemm)
Image from Naveen Pemmaraju, MD (@doctorpemm)
Image from Naveen Pemmaraju, MD (@doctorpemm)
Image from Naveen Pemmaraju, MD (@doctorpemm)
1
11
31
8,142
#ASH22 #MPNSM oral session. Standing room only ! @mpndoc kicking off session - an important dataset to discuss in our field asking the broader q what is association of BM fibrosis with other clinical parameters with #JAKi ? #BoneMarrowFibrosis @ASH_hematology
Image from Naveen Pemmaraju, MD (@doctorpemm)
Image from Naveen Pemmaraju, MD (@doctorpemm)
Image from Naveen Pemmaraju, MD (@doctorpemm)
Image from Naveen Pemmaraju, MD (@doctorpemm)
3
11
1
34
Farewell to our host @GioraSharf & team and to our host city #Netanya Israel 🇮🇱 for #MPNHz22 a quite memorable meeting !! Wonderful new connections & friendships !! Wishing all safe travels back home ! #MPNSM | @GabyHobbs @TheIACH @vijivenkatesh @PVReporter @mpdrc @harrisoncn1
Image from Naveen Pemmaraju, MD (@doctorpemm)
Image from Naveen Pemmaraju, MD (@doctorpemm)
Image from Naveen Pemmaraju, MD (@doctorpemm)
Image from Naveen Pemmaraju, MD (@doctorpemm)
1
4
1
22
PV Reporter retweeted
MPN_Hub (@MPN_Hub) profile picture
MPN_Hub
@MPN_Hub27 Oct 2022
Congratulations to Hans Hasselbalch on receiving the Medical Excellence Award during the 14th International Congress on MPN #MPNCongress2022, for his livelong dedication to improving the lives of patients with #MPN #MPNsm
Image from MPN_Hub (@MPN_Hub)
2
3
2
18
After being diagnosed with #PolycthemiaVera, Dave’s initial treatment wasn’t working, so he sought specialty care from #MPN experts @WeillCornell @nyphospital. He now encourages others to do the same: bit.ly/3cF0RFQ (cc: @GhaithAbuZeinah) #BloodCancerAwarenessMonth
Image from Silver MPN Center (@WCMSilverMPNCtr)
2
10
For your calendar: 2022 Texas MPN Workshop to gather global #MPNsm experts to dive into role of current & new therapies. Aug 26-27 in person & virtual. MPNRF is a proud sponsor. Info/register here: cancer.uthscsa.edu/node/7611 @mpdrc @doctorpemm @UTHealthSAMDA @PVreporter @MPN
1
6
12
This #CancerResearchMonth, Dr. @GhaithAbuZeinah emphasizes the importance of conducting #research in order to improve the lives of patients with #MyeloproliferativeNeoplasms at @WeillCornell and around the world. #mpnsm
Image from Silver MPN Center (@WCMSilverMPNCtr)
5
8
Disease Modification in Myelofibrosis: An Elusive Goal? ascopubs.org/doi/abs/10.1200…
Disease Modification in Myelofibrosis: An Elusive Goal?

Disease Modification in Myelofibrosis: An Elusive Goal?

ascopubs.org
9
2
29
ICYMI Monday’s 10:30am #ASH21 oral session hosted by @MPN_RF funded @mullallylab and @mpnlab (formerly funded) was packed with MPN research developments. 3 of the 6 presentations featured work in labs funded by MPNRF! #mpnsm
Image from MPN Research Foundation (@MPN_RF)
1
5
1
14
PV Reporter retweeted
MPN_Hub (@MPN_Hub) profile picture
MPN_Hub
@MPN_Hub11 Dec 2021
Congress| #ASH21| @AaronGerds, @ClevelandClinic, discusses results from the REVEAL study, a real-world cohort of patients with PV to date. Results showed elevated HCT levels (>45%), WBC (>12×109/L) and PLT counts (>400×109/L) are each associated with increased risk of TE. #MPNsm
Image from MPN_Hub (@MPN_Hub)
Image from MPN_Hub (@MPN_Hub)
Image from MPN_Hub (@MPN_Hub)
Image from MPN_Hub (@MPN_Hub)
8
9
Phase III trial of now FDA approved (in PV) RoPEG INFa2b (besremi) for 2nd line ET patients. Now enrolling #ASH21 ⁦@LLSusa⁩ #SergeVerstovsek #pharmessentia #mpnsm ⁦@doctorpemm⁩
Image from Ruben A. Mesa, MD (@mpdrc)
4
4
29
PV Reporter retweeted
Stephen Oh (@mpndoc) profile picture
Stephen Oh@mpndoc11 Dec 2021
🚨Big #ASH21 #mpnsm day with *4* oral sessions let's goooooooo! 💪💪💪 eventpilot.us/web/page.php?p… eventpilot.us/web/page.php?p… eventpilot.us/web/page.php?p… eventpilot.us/web/page.php?p…
Image from Stephen Oh (@mpndoc)
4
7
1
30
As we brace for a data deluge at ASH (4 oral MPN clinical sessions - unprecedented?) here is a case and unmet need based perspective on where we stand today with drug development for MF. #MPNSM ⁦@mpdrc⁩ ncbi.nlm.nih.gov/pubmed/3477…
3
13
PV Reporter retweeted
MPN_Hub (@MPN_Hub) profile picture
MPN_Hub
@MPN_Hub2 Nov 2021
In case you missed it check out our coverage of the 2021 International Congress on Myeloproliferative Neoplasms, which was held in a hybrid format from October 28-29, 2021. #mpnsm teapawt.org/i/events/1455578199358…
2
7
PV Reporter retweeted
MPN_Hub (@MPN_Hub) profile picture
MPN_Hub
@MPN_Hub28 Oct 2021
Congress| #2021MPNCongress| Ronald Hoffman, @IcahnMountSinai, talks about various candidate drugs to prevent MPN progression such as more potent JAK2 inhibitors, targeting P53, immune therapies and targeting the TPO/MPL axis. #mpnsm
Image from MPN_Hub (@MPN_Hub)
Image from MPN_Hub (@MPN_Hub)
Image from MPN_Hub (@MPN_Hub)
Image from MPN_Hub (@MPN_Hub)
4
10
#MPNSM | Recent pub in Annals of Hematology: Favorable survival with imetelstat in R/R MF pts compared w/ matched RWD from @MoffittNews. 1st presented at @EHA_Hematology. Thanks to co-authors @Ramikomrokji @jjkiladjian and those not yet tweeting. rdcu.be/cy675
Image from Andrew Kuykendall MD (@KuykendallMd)
3
7
1
42
Thanks @OncLive for highlighting our work @SilverMPNCenter that we hope will reform standard of care in PV to the best interest of our patients #mpnsm. @PVReporter . For more exciting data+Q&A on this, tune in April 8th 15.00 CST for mpn-mdsus2021.com/conference
OncLive.com (@OncLive) profile pictureOncLive.com
@OncLive5 Apr 2021
.@GhaithAbuZeinah Outlines Why Interferon-Alpha Should Be Offered to Both Low- and High-Risk Polycythemia Vera @WeillCornell @SilverMPNCenter #mpn ow.ly/vS1Y50EgCU6
Abu-Zeinah Outlines Why Interferon-Alpha Should Be Offered to Both Low- and High-Risk Polycythemia...

Abu-Zeinah Outlines Why Interferon-Alpha Should Be Offered to Both Low- and High-Risk Polycythemia...

Ghaith Abu-Zeinah, MD, shares what inspired the study examining IFN vs standard strategies, key findings from the research, and the clinical implications of these data on the PV treatment paradigm.

onclive.com
4
15
Protagonist is pleased to announce regulatory updates for investigational new drug rusfertide in polycythemia vera. Read the full press release here: investors.protagonist-inc.co…
Image from Protagonist Therapeutics (@ProtagonistTx)
1
6
Increased understanding of memory T-cell responses following SARS-CoV-2 infection in MPN and CML #mpnsm #cmlsm #bloodcancer #covid19 onlinelibrary.wiley.com/doi/…
Image from GUY'S MYELOID CENTRE (@G_ICEMD)
7
1
13
PV Reporter retweeted
VJHemOnc (@VJHemOnc) profile picture
VJHemOnc
@VJHemOnc18 Jan 2021
Our post-ASH #MPNs Sessions w/ @mpdrc @harrisoncn1 @doctorpemm & Srdan Verstovsek is now available on-demand! Watch it here 👉ow.ly/pwcL50Db5aE👈 #ASH20 #HemOnc #CTsm #MPNsm #PolycythemiaVera #Myelofibrosis #EssentialThrombocythemia #Mastocytosis
3
6
Load more